J-Pharma Enters into Non-Binding Term Sheet with European Biotech Company for JPH034
Filed with TSE · · 4 pages · English
On 6ix: 6ix.com/news/j-pharma-enters-into-non-binding-term-sheet-with-european-biotech-company-for-jph034
Earlier from J-Pharma Co.,Ltd
- Non-consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)
- Notice Regarding Issuance of New Shares as Restricted Stock Compensation to Directors and Executive Officers
- Matters Relating to Business Plans and Growth Potential
Later from J-Pharma Co.,Ltd
- J-Pharma Selected for Funding under AMED's Global Research and Development Support Project for the Treatment of Intractable/Rare Diseases
- Notice of Grant approval and Commencement of the Grant-Funded Project under AMED’s GRiT Program
- Non-consolidated Financial Results for the Six Months Ended September 30, 2026 (Under Japanese GAAP)
- Notice Regarding the Recognition of Non-operating Expenses (Foreign Exchange Losses)
Follow J-Pharma Co.,Ltd into a list and get an email when it puts out news.
Follow J-Pharma Co.,Ltd